Zomedica Corp. (NYSE: ZOM) reported Q2 EPS of ($0.01), $0.01 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $6.02 million versus the consensus estimate of $7.34 million.

For earnings history and earnings-related data on Zomedica Corp. (ZOM) click here.